Product Images Cisatracurium Besylate

This text appears to be a series of numeric values indicating percentages, including "+60%", "~60%", and "4 HR". Without additional context, it is not possible to provide a specific description of what these values represent or how they might be used.*

This text appears to be describing percentage values with symbols (+ and -) indicating whether they represent an increase or decrease. However, without further context, it is not clear what these percentages are referring to or what the abbreviation "HR" means.*

This is a label for a medication containing cisatracurium, which is administered intravenously. It comes in a 10 mL vial and should be used within 21 days after removal from refrigeration. It should not be frozen and should be protected from light. The label includes a code number, NDC number, and information about the manufacturer and distributor. The medication is a paralyzing agent and caution is advised when administering it intravenously.*

Cisatracurium Besylate Injection, USP is a solution administered through intravenous injection. The injection contains Cisatracurium Besylate as the active ingredient in 20mg/10mL strength for S/C 312 1 8% (3" to A1). The solution is available in 10mL Multipe Dose Vials and contains 0.8% benzyl alcohol as a preservative. Physicians must carefully administer the solution as it is a Preanesthetic Paralyzing Agent.*

This is a description of Cisatracurium Besylate Injection, USP, which is available in a concentration of 20mg/0mL (2mg/mL). Unfortunately, the last line of text appears to be a mistake from the process and is not readable.*